Cover Image
市場調查報告書

Nifedipine的中國市場:2010年∼2019年

Investigation Report on China Nifedipine Market, 2010-2019

出版商 China Research and Intelligence 商品編碼 337520
出版日期 內容資訊 英文 30 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
Nifedipine的中國市場:2010年∼2019年 Investigation Report on China Nifedipine Market, 2010-2019
出版日期: 2015年08月18日 內容資訊: 英文 30 Pages
簡介

中國現在,大概2億7,000萬人苦於高血壓。高血壓治療藥物Nifedipine,在中國市場登場以來,急速伸展其銷售量。該市場上,2014年德國的Bayer銷售額佔92%的高佔有率。

本報告提供中國的Nifedipine的專利及核準情況、銷售額、銷售量的變化與預測、價格趨勢、主要的製藥公司與其市場佔有率、競爭環境與其展望、主要製造商的簡介等。

第1章 Nifedipine的相關概念

  • 適應
  • 全球市場的銷售情形

第2章 中國的Nifedipine的市場簡介

  • 專利、核準情況
  • 主要製藥公司
  • 市場規模

第3章 中國的Nifedipine銷售情形

  • 銷售額
    • 總銷售額
    • 各地區的銷售額
  • 銷售量
    • 總銷售量
    • 各地區的銷售數

第4章 中國的主要Nifedipine製造商的市場佔有率

  • 銷售額為基礎市場佔有率
  • 銷售量為基礎市場佔有率

第5章 中國的Nifedipine的劑型相關調查

  • 各劑型的市場佔有率:銷售額為基礎
  • 各劑型的市場佔有率:銷售量為基礎

第6章 中國的醫院的Nifedipine的標準價格

  • Shanghai Shyndec Pharmaceutical Co., Ltd (商品名:Xinran)
  • Bayer (德國) (商品名:Adalat)
  • Jiangsu Haici Biological Pharmaceutical Co., Ltd
  • Guangdong Medi-world Pharmacy Co. Ltd.
  • Shanghai Sine Tianping Pharmaceutical Co., Ltd
  • China National Pharmaceutical Industry Corporation Ltd

第7章 中國市場中Nifedipine的主要製藥公司

  • Shanghai Shyndec Pharmaceutical Co., Ltd
  • Bayer (德國)
  • Jiangsu Haici Biological Pharmaceutical Co., Ltd
  • Guangdong Medi-world Pharmacy Co. Ltd.
  • China National Pharmaceutical Industry Corporation Ltd

第8章 中國的Nifedipine的市場預測

  • 市場規模的預測
  • 競爭情形的預測
目錄
Product Code: 1508303

The incidence of cardiovascular disease has kept going up in China. Currently, 290 million Chinese are suffering from cardiovascular diseases, among which 270 million are suffering from hyper tension, 2.50 million myocardial infarction, 4.5 million heart failure, 5 million pulmonary heart disease, 2.5 million rheumatic heart disease and 5 million congenital heart disease. And one out of five adults suffers from cardiovascular disease which is the leading killer of human health. During the period of 2002-2013, coronary heart disease reported an increase in its incidence. According to the statistics of National Health and Family Planning Commission of the People's Republic of China, the mortality of coronary heart disease in 2013 was 1008.6/1 million in city and 986.8/1 million in rural areas, both increasing slightly compared with 2012.

The synthesis of nifedipin by Bayer researchers in 1966 opened a new chapter in the treatment of cardiovascular diseases. Developed by Bayer in 1992, nifedipin controlled release tablet (Adalat) has given a new life to nifedipin and created a new dose of hypertension drug. So far, Adalat has benefited hundreds of millions of hypertension patients that include Chinese ones ever since it entered China in 1994.

Nifedipin develops fast after entering China with sales value exceeding 300 million since 2010 and 4 million in 2014. And Bayer (Germany) dominated the market with a share of over 92% in 2014 which still keeps growing. However, Bayer's market share for sales volume was only about 60% due to its high price. Against the background that more and more people are suffering from cardiovascular diseases at a younger age, nifedipine will enjoy a vast market. And local enterprises can make use of price advantage and enhance R&D so as to take up a share in the market.

Readers can get at least the following information through this report:

  • market size of nifedipine in China
  • competitive landscape of nifedipine market in China
  • price of nifedipine made by different enterprises in China
  • market outlook of nifedipine in China

The author suggests the following groups of people purchase this report:

  • manufacturers of cardiovascular drugs
  • investors/research institutions interested in Chinese medicine market
  • -any interest in Chinese medicine market, please contact CRI for customized survey service

Table of Contents

1. Related Concepts of Nifedipine

  • 1.1. Indication
  • 1.2. Sales Status in Global Market

2. Market Profile of Nifedipine in China

  • 2.1. Patent and Approval Information of Nifedipine in China
  • 2.2. Major Manufacturers
  • 2.3. Market Size

3. Survey on Nifedipine Sales in China, 2010-2014

  • 3.1. Sales Value
    • 3.1.1. Overall Sales Value
    • 3.1.2. Sales Value by Regions
  • 3.2. Sales Volume
    • 3.2.1. Overall Sales Volume
    • 3.2.2. Sales Volume by Regions

4. Survey on Market Share of Major Nifedipine Manufacturers in China, 2010-2014

  • 4.1. Market Share by Sales Value
  • 4.2. Market Share by Sales Volume

5. Survey on Dosage Forms of Nifedipine in China, 2010-2014

  • 5.1. Share of Different Dosage Forms by Sales Value
  • 5.2. Share of Different Dosage Forms by Sales Volume

6. Reference Price of Nifedipine in Chinese Hospitals in 2014

  • 6.1. Shanghai Shyndec Pharmaceutical Co., Ltd (Trade Name: Xinran)
  • 6.2. Bayer (Germany) (Trade Name: Adalat)
  • 6.3. Jiangsu Haici Biological Pharmaceutical Co., Ltd
  • 6.4. Guangdong Medi-world Pharmacy Co. Ltd.
  • 6.5. Shanghai Sine Tianping Pharmaceutical Co., Ltd
  • 6.6. China National Pharmaceutical Industry Corporation Ltd

7. Major Manufacturers of Nifedipine in Chinese Market, 2010-2014

  • 7.1. Shanghai Shyndec Pharmaceutical Co., Ltd
  • 7.2. Bayer (Germany)
  • 7.3. Jiangsu Haici Biological Pharmaceutical Co., Ltd
  • 7.4. Guangdong Medi-world Pharmacy Co. Ltd.
  • 7.5. China National Pharmaceutical Industry Corporation Ltd

8. Market Outlook of Nifedipine in China, 2015-2019

  • 8.1. Forecast of Market Size
  • 8.2. Forecast of Competitive Landscape

Table of Selected Charts

  • Chart Patent Status of Nifedipine in China
  • Chart Approval Information of Nifedipine in China
  • Chart Nifedipine Sales in China
  • Chart Sales Value of Nifedipine in China, 2010-2014
  • Chart Sales Value of Nifedipine in Some Regions in China, 2010-2014
  • Chart Sales Volume of Nifedipine in China, 2010-2014
  • Chart Sales Value and Market Share of Nifedipine Made by Bayer (Germany) in China, 2010-2014
  • Chart Sales Value and Market Share of Nifedipine Made by Shanghai Shyndec in China, 2010-2014
  • Chart Sales Value and Market Share of Nifedipine Tablet in China, 2010-2014
  • Chart Sales Value and Market Share of Nifedipine Capsule in China, 2010-2014
  • Chart Sales Value and Market Share of Nifedipine Pill in China, 2010-2014
  • Chart Price of Nifedipine Made by Shanghai Shyndec Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Nifedipine Made by Bayer (Germany) in Some Chinese Cities in 2014
  • Chart Price of Nifedipine Made by Jiangsu Haici Biological Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Nifedipine Made by Shinan Company in Some Chinese Cities in 2014
  • Chart Price of Nifedipine Made by Shanghai Sine Tianping Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Nifedipine Made by China National Pharmaceutical Industry Corporation Ltd in Some Chinese Cities in 2014
Back to Top